Environmental contaminants, sex hormones and SHBG in an elderly population.

Autor: Kushnir MM; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA; Department of Pathology, University of Utah, Salt Lake City, UT, USA. Electronic address: kushnmm@aruplab.com., Salihovic S; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Sweden., Bergquist J; Department of Pathology, University of Utah, Salt Lake City, UT, USA; Department of Chemistry, Analytical Chemistry, Uppsala University, Uppsala, Sweden., Lind PM; Department of Medical Sciences, Occupational and Environmental Medicine, Uppsala University, Uppsala, Sweden., Lind L; Department of Medical Sciences, Cardiovascular Epidemiology, Uppsala University, Uppsala, Sweden.

Publikováno v: Environmental research [Environ Res] 2024 Dec 15; Vol. 263 (Pt 1), pp. 120054. Date of Electronic Publication: 2024 Sep 26.

Plasma perfluoroalkyls are associated with decreased levels of proteomic inflammatory markers in a cross-sectional study of an elderly population

Autor: Salihovic, S., Lind, L., Larsson, A., Lind, P.M.

Publikováno v: In Environment International December 2020 145

Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease.

Autor: Salihovic S; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Nyström N; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden., Mathisen CB; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway and Faculty of Medicine, University of Oslo, Oslo, Norway., Kruse R; Department of Clinical Research Laboratory, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Olbjørn C; Department of Pediatrics and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway., Andersen S; Department of Pediatrics, Vestfold Hospital Trust, Tønsberg, Norway., Noble AJ; Translational Gastroenterology Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, United Kingdom.; Biomedical Research Center, University of Oxford, Oxford, United Kingdom., Dorn-Rasmussen M; Department of Paediatric and Adolescence Medicine, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark., Bazov I; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Perminow G; Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway., Opheim R; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway and Faculty of Medicine, University of Oslo, Oslo, Norway., Detlie TE; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway and Faculty of Medicine, University of Oslo, Oslo, Norway., Huppertz-Hauss G; Department of Gastroenterology, Telemark Hospital Trust, Skien, Norway., Hedin CRH; Karolinska Institutet, Department of Medicine Solna, Stockholm, Sweden.; Karolinska University Hospital, Gastroenterology unit, Department of Gastroenterology, Dermatovenereology and Rheumatology, Stockholm, Sweden., Carlson M; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Öhman L; Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Magnusson MK; Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Keita ÅV; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Söderholm JD; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., D'Amato M; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.; Gastrointestinal Genetics Lab, CIC bioGUNE - BRTA, Derio, Spain.; Department of Medicine & Surgery, LUM University, Casamassima, Italy., Orešič M; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Wewer V; Department of Paediatric and Adolescence Medicine, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark., Satsangi J; Translational Gastroenterology Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, United Kingdom.; Biomedical Research Center, University of Oxford, Oxford, United Kingdom., Lindqvist CM; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Burisch J; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.; Gastrounit, medical division, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark., Uhlig HH; Translational Gastroenterology Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, United Kingdom.; Biomedical Research Center, University of Oxford, Oxford, United Kingdom.; Department of Paediatrics, University of Oxford, Oxford, UK., Repsilber D; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Hyötyläinen T; School of Science and Technology, Örebro University, Örebro, Sweden., Høivik ML; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway and Faculty of Medicine, University of Oslo, Oslo, Norway., Halfvarson J; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. jonas.halfvarson@regionorebrolan.se.

Publikováno v: Nature communications [Nat Commun] 2024 Jun 03; Vol. 15 (1), pp. 4567. Date of Electronic Publication: 2024 Jun 03.

Immunotoxic, genotoxic, and endocrine disrupting impacts of polyamide microplastic particles and chemicals.

Autor: Alijagic A; Man-Technology-Environment Research Center (MTM), Örebro University, Örebro SE-701 82, Sweden; Inflammatory Response and Infection Susceptibility Centre (iRiSC), Faculty of Medicine and Health, Örebro University, Örebro SE-701 82, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro SE-701 82, Sweden. Electronic address: andi.alijagic@oru.se., Kotlyar O; Man-Technology-Environment Research Center (MTM), Örebro University, Örebro SE-701 82, Sweden; Centre for Applied Autonomous Sensor Systems (AASS), Mobile Robotics and Olfaction Lab (MRO), Örebro University, SE-701 82 Örebro, Sweden., Larsson M; Man-Technology-Environment Research Center (MTM), Örebro University, Örebro SE-701 82, Sweden., Salihovic S; Inflammatory Response and Infection Susceptibility Centre (iRiSC), Faculty of Medicine and Health, Örebro University, Örebro SE-701 82, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro SE-701 82, Sweden., Hedbrant A; Inflammatory Response and Infection Susceptibility Centre (iRiSC), Faculty of Medicine and Health, Örebro University, Örebro SE-701 82, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro SE-701 82, Sweden., Eriksson U; Man-Technology-Environment Research Center (MTM), Örebro University, Örebro SE-701 82, Sweden., Karlsson P; Department of Mechanical Engineering, Örebro University, Örebro SE-701 82, Sweden., Persson A; Inflammatory Response and Infection Susceptibility Centre (iRiSC), Faculty of Medicine and Health, Örebro University, Örebro SE-701 82, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro SE-701 82, Sweden., Scherbak N; Man-Technology-Environment Research Center (MTM), Örebro University, Örebro SE-701 82, Sweden., Färnlund K; AMEXCI AB, Karlskoga SE-691 51, Sweden., Engwall M; Man-Technology-Environment Research Center (MTM), Örebro University, Örebro SE-701 82, Sweden., Särndahl E; Inflammatory Response and Infection Susceptibility Centre (iRiSC), Faculty of Medicine and Health, Örebro University, Örebro SE-701 82, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro SE-701 82, Sweden.

Publikováno v: Environment international [Environ Int] 2024 Jan; Vol. 183, pp. 108412. Date of Electronic Publication: 2023 Dec 29.

Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid.

Autor: Zahm S; International Agency for Research on Cancer, Lyon, France., Bonde JP; International Agency for Research on Cancer, Lyon, France., Chiu WA; International Agency for Research on Cancer, Lyon, France., Hoppin J; International Agency for Research on Cancer, Lyon, France., Kanno J; International Agency for Research on Cancer, Lyon, France., Abdallah M; International Agency for Research on Cancer, Lyon, France., Blystone CR; International Agency for Research on Cancer, Lyon, France., Calkins MM; International Agency for Research on Cancer, Lyon, France., Dong GH; International Agency for Research on Cancer, Lyon, France., Dorman DC; International Agency for Research on Cancer, Lyon, France., Fry R; International Agency for Research on Cancer, Lyon, France., Guo H; International Agency for Research on Cancer, Lyon, France., Haug LS; International Agency for Research on Cancer, Lyon, France., Hofmann JN; International Agency for Research on Cancer, Lyon, France., Iwasaki M; International Agency for Research on Cancer, Lyon, France., Machala M; International Agency for Research on Cancer, Lyon, France., Mancini FR; International Agency for Research on Cancer, Lyon, France., Maria-Engler SS; International Agency for Research on Cancer, Lyon, France., Møller P; International Agency for Research on Cancer, Lyon, France., Ng JC; International Agency for Research on Cancer, Lyon, France., Pallardy M; International Agency for Research on Cancer, Lyon, France., Post GB; International Agency for Research on Cancer, Lyon, France., Salihovic S; International Agency for Research on Cancer, Lyon, France., Schlezinger J; International Agency for Research on Cancer, Lyon, France., Soshilov A; International Agency for Research on Cancer, Lyon, France., Steenland K; International Agency for Research on Cancer, Lyon, France., Steffensen IL; International Agency for Research on Cancer, Lyon, France., Tryndyak V; International Agency for Research on Cancer, Lyon, France., White A; International Agency for Research on Cancer, Lyon, France., Woskie S; International Agency for Research on Cancer, Lyon, France., Fletcher T; International Agency for Research on Cancer, Lyon, France., Ahmadi A; International Agency for Research on Cancer, Lyon, France., Ahmadi N; International Agency for Research on Cancer, Lyon, France., Benbrahim-Tallaa L; International Agency for Research on Cancer, Lyon, France., Bijoux W; International Agency for Research on Cancer, Lyon, France., Chittiboyina S; International Agency for Research on Cancer, Lyon, France., de Conti A; International Agency for Research on Cancer, Lyon, France., Facchin C; International Agency for Research on Cancer, Lyon, France., Madia F; International Agency for Research on Cancer, Lyon, France., Mattock H; International Agency for Research on Cancer, Lyon, France., Merdas M; International Agency for Research on Cancer, Lyon, France., Pasqual E; International Agency for Research on Cancer, Lyon, France., Suonio E; International Agency for Research on Cancer, Lyon, France., Viegas S; International Agency for Research on Cancer, Lyon, France., Zupunski L; International Agency for Research on Cancer, Lyon, France., Wedekind R; International Agency for Research on Cancer, Lyon, France., Schubauer-Berigan MK; International Agency for Research on Cancer, Lyon, France.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Jan; Vol. 25 (1), pp. 16-17. Date of Electronic Publication: 2023 Nov 30.